145 related articles for article (PubMed ID: 372140)
1. Phenobarbital in prophylaxis of neonatal jaundice. A control trial of two regimens.
Salle B; Pasquer P; Desebbe C; Rouzioux JM; Barouty B
Helv Paediatr Acta; 1977 Sep; 32(3):221-6. PubMed ID: 372140
[TBL] [Abstract][Full Text] [Related]
2. The course of hyperbilirubinemia in the very low birth weight infant treated with phenobarbital.
Anwar M; Valdivieso J; Hiatt IM; Hegyi T
J Perinatol; 1987; 7(2):145-8. PubMed ID: 3505611
[TBL] [Abstract][Full Text] [Related]
3. Phenobarbital prophylaxis of neonatal hyperbilirubinemia. Evaluation of a nightly dose.
Thomas CR
Obstet Gynecol; 1977 Nov; 50(5):607-10. PubMed ID: 909669
[TBL] [Abstract][Full Text] [Related]
4. Effect on neonatal hyperbilirubinemia of phenobarbital during pregnancy or after birth: practical value of the treatment in a population with high risk of unexplained severe neonatal jaundice.
Valaes T; Petmezaki S; Doxiadis SA
Birth Defects Orig Artic Ser; 1970 Jun; 6(2):46-54. PubMed ID: 4941650
[No Abstract] [Full Text] [Related]
5. Routine phenobarbital for prevention of neonatal hyperbilirubinemia.
Thomas CR
Obstet Gynecol; 1976 Mar; 47(3):304-8. PubMed ID: 1250562
[TBL] [Abstract][Full Text] [Related]
6. Treatment of neonatal jaundice with phenobarbitone.
Ramboer C; Thompson RP; Williams R
Gut; 1969 May; 10(5):414. PubMed ID: 4890538
[No Abstract] [Full Text] [Related]
7. [Effect of minimal doses of phenobarbital on bilirubinemia in the newborn infant].
del Castillo ED; Abdo-Bassol F; Jasso-Gutiérrez L
Bol Med Hosp Infant Mex; 1976; 33(1):131-6. PubMed ID: 1247472
[TBL] [Abstract][Full Text] [Related]
8. [Dynamic changes in the level of serum bilirubin in newborn infants treated with enzyme inducers].
Daskalova E; Tsankova TS
Akush Ginekol (Sofiia); 1977; 16(1):66-72. PubMed ID: 324302
[No Abstract] [Full Text] [Related]
9. Prophylaxis of neonatal hyperbilirubinemia with phenobarbital.
Halpin TF; Jones AR; Bishop HL; Lerner S
Obstet Gynecol; 1972 Jul; 40(1):85-90. PubMed ID: 4625595
[No Abstract] [Full Text] [Related]
10. [Preventive drug therapy of hyperbilirubinemia in full-term infants].
Langer P; Berg G; Endig W
Kinderarztl Prax; 1977 Jan; 45(1):11-4. PubMed ID: 556483
[No Abstract] [Full Text] [Related]
11. [Transitory bilirubinemia in the newborn infant. 1. For and against phenobarbital prophylaxis of hyperbilirubinemia in the term infant].
Menzel K; Buchenau W; Linke M; Thomas A; Töpke B; Wiedemann G
Padiatr Grenzgeb; 1982; 21(1):1-7. PubMed ID: 7099666
[No Abstract] [Full Text] [Related]
12. Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants. A controlled study of bilirubin disappearance and infant behavior.
Wallin A; Boréus LO
Acta Paediatr Scand; 1984 Jul; 73(4):488-97. PubMed ID: 6380212
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetics of injectable phenobarbital in the premature infant. Study of a new lyophilized form].
Kossmann JC; Ribon B; Claris O; Brazier JL; Salle B
Arch Fr Pediatr; 1985 Apr; 42(4):317-20. PubMed ID: 4004495
[TBL] [Abstract][Full Text] [Related]
14. [The influence of combined therapy with orotic acid and phenobarbital on the level of serum bilirubin in premature infants].
Hinkel GK; Schwarze R; Kintzel HW
Schweiz Med Wochenschr; 1972 Mar; 102(10):331-5. PubMed ID: 5034967
[No Abstract] [Full Text] [Related]
15. [Therapeutic and preventive values of phenobarbital in the prevention and treatment of neonatal jaundice].
Gagyi D; Frank K
Monatsschr Kinderheilkd (1902); 1971 Dec; 119(12):614-7. PubMed ID: 5003415
[No Abstract] [Full Text] [Related]
16. [Results of icterus prevention using phenobarbital in 1500 newborn and premature infants].
Menzel K; Braun W
Kinderarztl Prax; 1972 Feb; 40(2):62-9. PubMed ID: 4663434
[No Abstract] [Full Text] [Related]
17. Phenobarbitone prophylaxis for neonatal jaundice in babies with birth weight 1000-1499 grams.
Kumar R; Narang A; Kumar P; Garewal G
Indian Pediatr; 2002 Oct; 39(10):945-51. PubMed ID: 12428041
[TBL] [Abstract][Full Text] [Related]
18. [The influence of short time phenobarbital treatment on neonatal jaundice].
Zwacka G; Frenzel J
Padiatr Padol; 1971 Mar; 6(1):102-7. PubMed ID: 5155604
[No Abstract] [Full Text] [Related]
19. [Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].
Centa A; Camera G; Piccinini A; De Pietro P; Tomatis C
Minerva Pediatr; 1976 Apr; 28(15):911-21. PubMed ID: 11400
[No Abstract] [Full Text] [Related]
20. Effectiveness and safety of prenatal phenobarbital for the prevention of neonatal jaundice.
Valaes T; Kipouros K; Petmezaki S; Solman M; Doxiadis SA
Pediatr Res; 1980 Aug; 14(8):947-52. PubMed ID: 7422399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
